News Circassia gives up on allergy treatments after second trial ... UK biotech to focus on respiratory drugs after house dust mite therapy fails.
News AZ strikes COPD deal with Circassia, suffers setback with bl... FDA rejects blood potassium drug for second time.
News Good news for GSK’s next generation asthma drug Results mean patients could switch to once-daily inhaler use
News Propeller Health to bring smart inhaler tech to Novartis' Br... Partnership will focus on COPD in Europe.
News Stop obsessing about generic Advair, says GSK's Witty Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.
News Novartis’ COPD combo show benefits in switching from establi... A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to N
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
